Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
about
Present Advances and Future Perspectives of Molecular Targeted Therapy for OsteosarcomaShock wave-induced ATP release from osteosarcoma U2OS cells promotes cellular uptake and cytotoxicity of methotrexateDownregulation of BZW2 inhibits osteosarcoma cell growth by inactivating the Akt/mTOR signaling pathway.Molecular genetics of osteosarcoma.mTOR Inhibition Mitigates Enhanced mRNA Translation Associated with the Metastatic Phenotype of Osteosarcoma Cells In Vivo.Estrogen receptor β exhibited anti-tumor effects on osteosarcoma cells by regulating integrin, IAP, NF-kB/BCL-2 and PI3K/Akt signal pathwaymiR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14.Understanding the Osteosarcoma Pathobiology: A Comparative Oncology Approach.Overexpressed circPVT1, a potential new circular RNA biomarker, contributes to doxorubicin and cisplatin resistance of osteosarcoma cells by regulating ABCB1.miR‑15a represses cancer cell migration and invasion under conditions of hypoxia by targeting and downregulating Bcl‑2 expression in human osteosarcoma cells.Suppressive roles of A3AR and TMIGD3 i1 in osteosarcoma malignancy.Ovol2 induces mesenchymal-epithelial transition via targeting ZEB1 in osteosarcoma.Clinical Relevance of Genomic Changes in Recurrent Pediatric Solid TumorsScaffolds as Structural Tools for Bone-Targeted Drug Delivery
P2860
Q26750631-FF570635-B5EF-4DE9-A88C-4BEEA6B9328AQ37307686-5BF7CDD0-B3E0-4C20-98E3-9331E7D8885FQ38632877-84CE6907-6387-490B-8B17-6E2ECEFA8475Q38985480-B7CA970B-4C81-4281-BFD8-07F9B55AA681Q39656594-BCC827BE-1410-45C6-B479-1C3BF0C982F7Q42655390-AF1528FF-2248-4015-B834-05F80C6CB37AQ47121115-62B3D2F9-22D7-4915-BAF6-BB8C95F77F43Q47132356-C75BF8B2-152D-4F0F-8C2A-4F68907BEB1DQ52645998-8E708B98-24F7-4CEE-B067-4E99D429C271Q52683999-AE7AB770-C62C-4430-B07B-F0F22E9D52B0Q52779219-EDDA2402-8BA9-48BF-8C09-218A24478353Q55224098-AEF0B67B-D13D-4550-9AAC-C68610C41F7AQ58751530-0B1637D7-5809-4916-A0C5-CCA00AA5BC49Q58794823-804F08A1-C0D3-41BB-974F-DF3FFCEED8A9
P2860
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@ast
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@en
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@nl
type
label
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@ast
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@en
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@nl
prefLabel
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@ast
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@en
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@nl
P2860
P3181
P1476
Osteosarcoma Genetics and Epigenetics: Emerging Biology and Candidate Therapies
@en
P2093
Chand Khanna
James J Morrow
P2860
P304
P3181
P356
10.1615/CRITREVONCOG.2015013713
P407
P577
2015-01-01T00:00:00Z